Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Cardiothorac Vasc Anesth ; 37(1): 65-72, 2023 01.
Artículo en Inglés | MEDLINE | ID: mdl-36307353

RESUMEN

OBJECTIVE: The authors aimed to compare the anti-inflammatory and antioxidant effects of propofol and sevoflurane in children with cyanotic congenital heart disease (CCHD) undergoing cardiac surgery with cardiopulmonary bypass. DESIGN: Prospective, randomized, double-blind study. SETTING: Single center, university hospital. PARTICIPANTS: Children ages 1-10 years with CCHD undergoing elective cardiac surgery with cardiopulmonary bypass. INTERVENTIONS: Children were randomized to receive general anesthesia with either sevoflurane (group S) or propofol (group P). Systemic inflammatory response syndrome (SIRS) occurrence was assessed at the end of the surgery and at the sixth, 12th, and 24th postoperative hours. Blood samples were obtained at 4 times: after anesthesia induction (T0), after release of the aortic cross-clamp (T1), at the end of the surgery (T2), and at the postoperative 24th hour (T3). The serum levels of interleukin 6 and tumor necrosis factor alpha, and the total antioxidant status (TAS) and total oxidant status, were analyzed. RESULTS: SIRS was more common in group S than in group P at all times (p = 0.020, p = 0.036, p = 0.004, p = 0.008). There were no significant differences between the groups in the mean tumor necrosis factor alpha and interleukin 6 levels at any time. The TAS level at T2 was higher in group P than group S (p = 0.036). The serum TAS level increased at T2 compared with T0 in group P, but it decreased in group S (p = 0.041). CONCLUSION: The results showed that propofol provided a greater antioxidant effect and reduced SIRS postoperatively more than sevoflurane in children with CCHD undergoing cardiac surgery.


Asunto(s)
Antiinflamatorios , Antioxidantes , Cardiopatías Congénitas , Propofol , Sevoflurano , Niño , Preescolar , Humanos , Lactante , Anestésicos por Inhalación/uso terapéutico , Anestésicos Intravenosos/uso terapéutico , Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Cianosis , Cardiopatías Congénitas/cirugía , Interleucina-6 , Propofol/uso terapéutico , Estudios Prospectivos , Sevoflurano/uso terapéutico , Síndrome de Respuesta Inflamatoria Sistémica , Factor de Necrosis Tumoral alfa
2.
Cardiol Young ; 33(10): 1950-1955, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-36419327

RESUMEN

The aim of this study was to present the clinical and microbiological characteristics of patients with infective endocarditis.A retrospective evaluation was made of patients diagnosed with infective endocarditis between 1995 and 2021. The clinical and laboratory characteristics of the patients were recorded together with conditions constituting a risk for the development of endocarditis, treatment, and surgical outcomes.Evaluation was made of 68 patients with a mean age of 7.3 years (3 months-17 years), diagnosed with infective endocarditis. An underlying cause of CHD was determined in 47 (69%) patients and rheumatic valve disease in 3 (4.4%). There was no structural heart disease in 18 (26%) patients of whom 13 of them had other risk factors. A causative organism was found in 41 (60%) cases, and the microorganism most often determined was viridans group streptococcus. No difference was determined between the patients diagnosed before and after 2007 in respect of the frequency of viridans streptococcus (p > 0.05). Septic emboli were seen in 18 (26%) patients, of which 17 required surgical treatments. In 5 of 11 (16.6%) patients with mortality, the agent was S. aureus. Of the total 28 (41%) patients were evaluated as hospital-acquired endocarditis. The most frequently determined agents in this group were staphylococcus epidermidis and S. aureus.Although CHDs continue to be the greatest risk factor for endocarditis, there is an increasing frequency of endocarditis in patients with no structural heart disease. Mortality rates are still high in infective endocarditis, especially in S. aureus endocarditis.


Asunto(s)
Endocarditis Bacteriana , Endocarditis , Cardiopatías , Humanos , Niño , Staphylococcus aureus , Estudios Retrospectivos , Endocarditis Bacteriana/complicaciones , Endocarditis Bacteriana/epidemiología , Endocarditis Bacteriana/diagnóstico , Endocarditis/complicaciones , Endocarditis/epidemiología , Endocarditis/microbiología
4.
Heart Lung Circ ; 24(7): e118-21, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25937396

RESUMEN

Aortic regurgitation (AR) is a rare complication of transcatheter closure of perimembranous ventricular septal defects (pmVSD). It results from iatrogenic pinching of the aortic valve by the VSD occluder or perforation by the catheter. It is usually detected during control echocardiography (ECHO). The current study reports the first case of a late AR, which resulted from late right coronary cusp perforation by the VSD occluder. The current manuscript discusses the possible causes of late cusp erosion due to occluder, advantages of early operation in such cases, and an alternative treatment method where the occluder removal is not possible at the operation.


Asunto(s)
Insuficiencia de la Válvula Aórtica/etiología , Insuficiencia de la Válvula Aórtica/cirugía , Válvula Aórtica/lesiones , Cateterismo Cardíaco/efectos adversos , Defectos del Tabique Interventricular/cirugía , Válvula Aórtica/diagnóstico por imagen , Insuficiencia de la Válvula Aórtica/diagnóstico por imagen , Niño , Defectos del Tabique Interventricular/diagnóstico por imagen , Humanos , Masculino , Ultrasonografía
5.
Cardiol Young ; 24(3): 510-4, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23694855

RESUMEN

INTRODUCTION: A variety of patch materials have been used in the repair of intracardiac defects. We evaluated the short- and mid-term clinical and echocardiography results of glutaraldehyde-preserved bovine pericardium patches used to repair intracardiac defects in our clinic. METHODS AND RESULTS: This study examines the short- (up to 30 days post-operatively) and mid-term (up to 24 months post-operatively) results of 533 patients with intracardiac defects who underwent surgical correction with glutaraldehyde-preserved bovine pericardium patches between 2004 and 2010 at a university clinic. Short- and mid-term post-operative echocardiographic studies showed no evidence of calcification, thrombus, or aneurysmal dilatation on the patch. Vegetation developed in two (0.37%) of the 533 patients. CONCLUSION: These results that have been obtained from a group of large number of patients imply that the glutaraldehyde-preserved bovine pericardium patches may be preferable in the closure of cardiac defects because of their low complication rates and ease of use.


Asunto(s)
Bioprótesis , Cardiopatías Congénitas/cirugía , Xenoinjertos , Pericardio/trasplante , Animales , Bovinos , Niño , Preescolar , Femenino , Glutaral , Humanos , Lactante , Masculino , Soluciones Preservantes de Órganos , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento
6.
Heart Lung Circ ; 22(8): 682-4, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23265691

RESUMEN

A 48 year-old man was admitted to our hospital because of coughing with dispnoea and chest pain. On physical examination he showed marked respiratory difficulty, with a respiratory rate of 25 breaths per minute, and his jugular veins were mildly distended. Transthoracic echocardiography showed a cystic mass located in the diaphragmatic surface of the right ventricular wall without any protrusion into the ventricular cavity. These cardiac and also bilateral pulmonary hydatic cysts were demonstrated by thoracic CT imaging. There were three hydatic cysts which were located in the right middle lobe medial segment (20 mm × 20 mm) and two of them were located in the left lower lobe laterobazal segment (15 mm × 15 mm and 17 mm × 14 mm). Extracorporeal bypass via median sternotomy was used and all components of hydatid cysts in heart and lungs were removed in same session. Patient recovered well. So one-stage surgery by median sternotomy is an excellent approach for cardiac and lung cyst hydatid.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/métodos , Equinococosis Pulmonar , Cardiopatías , Ventrículos Cardíacos , Equinococosis Pulmonar/diagnóstico por imagen , Equinococosis Pulmonar/fisiopatología , Equinococosis Pulmonar/cirugía , Cardiopatías/diagnóstico por imagen , Cardiopatías/parasitología , Cardiopatías/fisiopatología , Cardiopatías/cirugía , Ventrículos Cardíacos/diagnóstico por imagen , Ventrículos Cardíacos/parasitología , Ventrículos Cardíacos/fisiopatología , Ventrículos Cardíacos/cirugía , Humanos , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA